1-3 of 3
Z. Alexander Cao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

Free
Jeffrey L. Brown, Z. Alexander Cao, Maria Pinzon-Ortiz, Jane Kendrew, Corinne Reimer, Shenghua Wen, Joe Q. Zhou, Mohammad Tabrizi, Steve Emery, Brenda McDermott, Lourdes Pablo, Patricia McCoon, Vahe Bedian, David C. Blakey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (1): 145–156.
https://doi.org/10.1158/1535-7163.MCT-09-0554
Published: 12 January 2010
View articletitled, A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
Open the PDF for A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models in another window
Includes: Supplementary data
Journal Articles

CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo

Free
Z. Alexander Cao, Kathryn E. Bass, Sriram Balasubramanian, Liang Liu, Brian Schultz, Erik Verner, YuQin Dai, Rafael A. Molina, Jack R. Davis, Shawn Misialek, Martin Sendzik, Christine J. Orr, Ling Leung, Ondine Callan, Peter Young, Stacie A. Dalrymple, Joseph J. Buggy
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (7): 1693–1701.
https://doi.org/10.1158/1535-7163.MCT-06-0042
Published: 04 August 2006
View articletitled, CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo
Open the PDF for CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo in another window
Journal Articles

CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo

Free
Joseph J. Buggy, Z. Alexander Cao, Kathryn E. Bass, Erik Verner, Sriram Balasubramanian, Liang Liu, Brian E. Schultz, Peter R. Young, Stacie A. Dalrymple
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (5): 1309–1317.
https://doi.org/10.1158/1535-7163.MCT-05-0442
Published: 26 May 2006
View articletitled, CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo
Open the PDF for CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo in another window